Kaiyu Qian
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 14
-
- Ferroptosis and cancer prognosis 21
- Renal cell carcinoma treatment 11
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 15
- Ubiquitin and proteasome pathways 10
- Renal and related cancers 9
- Cancer-related gene regulation 6
- Toxicology top 10%
-
- Bladder and Urothelial Cancer Treatments 14
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Kaiyu Qian
71 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 545
- Pulmonary and Respiratory Medicine 500
- Molecular Biology 959
- Oncology 230
- Toxicology 22
Countries citing papers authored by Kaiyu Qian
This map shows the geographic impact of Kaiyu Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiyu Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiyu Qian more than expected).
Fields of papers citing papers by Kaiyu Qian
This network shows the impact of papers produced by Kaiyu Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiyu Qian. The network helps show where Kaiyu Qian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kaiyu Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 35 | |
| 8 | 2024 | 11 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 9 | |
| 17 | 2020 | 20 | |
| 18 | 2020 | 16 | |
| 19 | 2018 | 21 | |
| 20 | Challenges of Ethical Reviews in China’s Biobanks | 2017 | 1 |
About Kaiyu Qian
Kaiyu Qian is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 76 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (21 papers), Epigenetics and DNA Methylation (15 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer, Lipids, and Metabolism (14 papers), Renal cell carcinoma treatment (11 papers), Ubiquitin and proteasome pathways (10 papers), Renal and related cancers (9 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Cancer Research (545 citations), Pulmonary and Respiratory Medicine (500 citations) and Molecular Biology (959 citations). Kaiyu Qian has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yu Xiao, Xinghuan Wang, Gang Wang, Lingao Ju, Xuefeng Liu, Guofeng Qian, Yejinpeng Wang, Chin‐Lee Wu, Lushun Yuan and Songtao Cheng.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.